SLC12A1 and Bartter syndrome: BS type 1 represents 11% of the cohort (3 of 27): patients SOR0079, SOR0082 and SOR0098 carried two pathogenic or likely pathogenic variants in compound heterozygosity in the SLC12A1 gene, thus satisfying criteria for a conclusive diagnosis of Bartter syndrome type 1.